Ben Schwartz

Ben Schwartz is Associate Editor, Contemporary OB/GYN.

Articles by Ben Schwartz

ART

To address limitations in previous literature on associations between ART and worse perinatal outcomes in offspring, researchers from Finland analyzed potentially harmful effects of ART using a sibling-comparison model approach. PLUS: Consumer and personal care products and BP in pregnancy. ALSO: How can racial disparities in breastfeeding be reduced in the American South?

A recently published cross-sectional analysis examined how common IPV, sexual assault, and PTSD are among this population and whether these exposures are associated with a woman’s menopause experience.

Women with silicone breast implants may be at increased risk for several rare adverse events, according to the first comprehensive study of long-term outcomes since the implants were reapproved. PLUS: Does delayed childbearing contribute to rates of multiple birth? ALSO: Does prenatal pollution exposure impact a newborn’s thyroid function?

A new report shows that over a 10-year period in the United States, rates of severe maternal morbidity increased and age, race, and income, all played a role in disparities in specific related trends. PLUS: How are most women informed of a breast cancer diagnosis? ALSO: Does gestational diabetes signal long-term risk for mothers and their children?

The first-ever guidelines for perimenopausal depression have been developed by The North American Menopause Society and the National Network on Depression Centers Women and Mood Disorders Task Group. PLUS: Are female sterilization rates and cognitive disability linked? ALSO: How does delivery mode in twin pregnancies impact maternal morbidity rates?

A recent study looked at whether a cost-effective finger-prick whole-blood test for toxoplasmosis can reliably detect the presence of the parasite Toxoplasma gondii. PLUS: Cell-free DNA (cfDNA) tests are increasingly being offered to women in the first trimester of pregnancy but results from a recent study suggest cfDNA tests may not significantly reduce miscarriage risk.

Research presented during the Pediatric Academic Society (PAS) 2018 Meeting suggests that when it comes to decision-making about hormone therapy (HT), transgender teens and their parents may have different views about preserving biologic fertility.